KI

Kazuhiro Ito

RE Respivert: 5 patents #5 of 32Top 20%
PL Pulmocide Limited: 1 patents #1 of 8Top 15%
TL Topivert Pharma Limited: 1 patents #7 of 21Top 35%
Overall (2017): #20,595 of 506,227Top 5%
6
Patents 2017

Issued Patents 2017

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
9850231 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors Catherine Elisabeth Charron, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw, Rudy Laurent Maria Broeckx +2 more 2017-12-26
9834560 Compounds John King-Underwood, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2017-12-05
9732098 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative Simon Fraser Hunt, Stuart Thomas Onions, Vladimir Sherbukhin, Euan Alexander Fraser Fordyce, Peter John Murray +2 more 2017-08-15
9724347 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors Catherine Elisabeth Charron, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw 2017-08-08
9701670 Pyrazolyl-ureas as kinase inhibitors Claire Anne Marie Cariou, Catherine Elisabeth Charron, Euan Alexander Fraser Fordyce, Daniel Hamza, Matthew Colin Thor Fyfe +6 more 2017-07-11
9637494 Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors John King-Underwood, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2017-05-02